CAMP4 Therapeutics Advancing a pipeline of ASO-based, RNA-targeting therapeutics with the aim to restore healthy protein levels
Cosigns
Team
Funding
- Total raised
- $370M
- Last valuation
- Undisclosed
- Series
- Post-IPO equity
Data current as of December 1, 2025